Agomelatine

Agomelatine Research Standard

Agomelatine is a synthetic melatonergic agent and a structural analogue of melatonin. In laboratory research, it is classified as an atypical psychotropic reference standard, functioning as a selective agonist at melatonin MT1 and MT2 receptors and a selective antagonist at 5-HT2C serotonin receptors. It is widely utilized in neuroscience research to investigate circadian rhythm resynchronization, neurogenesis, and the molecular mechanisms underlying mood-related neuropharmacology in experimental models.

Physical & Handling Properties

Mechanism of Action & Research Context

Agomelatine’s research utility is defined by its unique dual-action profile, distinct from conventional monoamine-based agents.

• Melatonergic Agonism: Agomelatine binds with high affinity to MT1 and MT2 melatonin receptors, mimicking the signaling of endogenous melatonin. This is used in experimental models to probe the resynchronization of circadian rhythms and the modulation of sleep-wake cycle disturbances.

• 5-HT2C Antagonism: By acting as a selective antagonist at 5-HT2C receptors, the compound disinhibits the release of norepinephrine and dopamine, particularly within the frontal cortex. Researchers utilize this mechanism to study the synergistic interplay between melatonergic signaling and monoaminergic release in neuroplasticity models.

• Neuroprotective Signaling: Investigations focus on the compound’s ability to promote hippocampal neurogenesis, upregulate BDNF expression, and improve neuronal plasticity, providing a probe for studying resilience in neurodegenerative or stress-response paradigms.

Research Applications

Agomelatine is a specialized reagent essential for comparative pharmacological and circadian biology research.

Primary fields of in vitro and laboratory investigation include:

• Circadian Biology: Mapping the effects of MT1/MT2 receptor modulation on the central clock and peripheral oscillator function.

• Neurogenesis Studies: Analyzing the role of 5-HT2C antagonism in hippocampal proliferation, maturation, and survival of neurons.

• Comparative Pharmacodynamics: Benchmarking agomelatine against standard SSRIs or melatonin receptor ligands to delineate differences in monoaminergic signaling and synaptic plasticity.

• Signaling Pathway Analysis: Utilizing agomelatine to elucidate the cross-talk between melatonin and serotonin receptor pathways in corticolimbic structures.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

• Seltorexant
• GB-115
• L-Tetrahydropalmatine (L-THP)
• Phenibut

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.